Publications

Rupprechter, S, G Morinan, Y Peng, T Foltynie, K Sibley, RS Weil, LA Leyland, et al. 2021. “A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease. Sensors (Basel). 2021 Aug 12;21(16):5437. Doi: 10.3390/S21165437. PMID: 34450879.”. Sensors (Basel).

Videnovic, A, AW Amara, C Comella, PK Schweitzer, H Emsellem, K Liu, AL Sterkel, et al. 2021. “Solriamfetol for Excessive Daytime Sleepiness in Parkinson’s Disease: Phase 2 Proof-of-Concept Trial. Mov Disord. 2021 Oct;36(10):2408-2412. Doi: 10.1002/Mds.28702. Epub 2021 Jun 30. PMID: 34191352.”. Mov Disord.

Hauser, RA, PA LeWitt, and CL Comella. 2021. “On Demand Therapy for Parkinson’s Disease Patients: Opportunities and Choices. Postgrad Med. 2021 Sep;133(7):721-727. Doi: 10.1080/00325481.2021.1936087.”. Postgrad Med.

Hauser, RA, SH Mehta, D Kremens, D Chernick, and AE Formella. 2021. “Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People With Parkinson’s Disease and Dyskinesia. Neurol Ther. 2021 Dec;10(2):739-751. Doi: 10.1007/S40120-021-00256-1.”. Neurol Ther.

Hauser, RA, RR Walsh, R Pahwa, D Chernick, and AE Formella. 2021. “Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson’s Disease. Front Neurol. 2021 Mar 26;12:645706. Doi: 10.3389/Fneur.2021.645706. ECollection 2021.PMID: 33841311.”. Front Neurol.

Mehta, SH, R Pahwa, CM Tanner, RA Hauser, and R Johnson. 2021. “Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients With Parkinson’s Disease and Dyskinesia. Neurol Ther. 2021 Jun;10(1):307-320. Doi: 10.1007/S40120-021-00246-3”. Neurol Ther.

Naito, A, AM Wills, TF Tropea, A Ramirez-Zamora, RA Hauser, D Martino, TH Turner, and . 2021. “Expediting Telehealth Use in Clinical Research Studies: Recommendations for Overcoming Barriers in North America. NPJ Parkinsons Dis 2021;7:34. Doi: 10.1038/S41531-021-00177-8.PMID: 33846349”. NP J Parkinsons Dis.

Hauser, RA, G Banisadr, K Vuong, D Freilich, S Fisher, and R D’Souza. 2021. “Real-World Experience With Carbidopa-Levodopa Extended-Release Capsules (Rytary®): Results of a Nationwide Dose Conversion Survey. Parkinsons Dis. 2021 Feb 19;2021:6638088. Doi: 10.1155/2021/6638088. ECollection 2021.PMID: 33688424”. Parkonsons Dis.

Patel, AT, MF Lew, K Dashtipour, S Isaacson, RA Hauser, W Ondo, P Maisonobe, S Wietek, B Rubin, and A Brashear. 2021. “Sustained Functional Benefits After a Single Set of Injections With AbobotulinumtoxinA Using a 2-ML Injection Volume in Adults With Cervical Dystonia: 12-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study.”. ECollection.

Jenner, P, A Mori, SD Aradi, and RA Hauser. 2021. “Istradefylline - a First Generation Adenosine A2A antagonist for the Treatment of Parkinson’s Disease. Expert Rev Neurother 2021;21:317-333.”. Expert Rev Neurother.